Lockdown Lifestyle: Engaging the invisible Enemy

Tejas N. Wanjari (1) , Gaurav Sawarkar (2)
(1) Department of Rachana Sharir, Mahatma Gandhi Ayurved College, Hospital & Research Centre, Salod (H), Datta Meghe Institute of Medical Sciences (DU), Wardha, Maharashtra, India, India ,
(2) Department of Rachana Sharir, Mahatma Gandhi Ayurved College, Hospital & Research Centre, Salod (H), Datta Meghe Institute of Medical Sciences (DU), Wardha, Maharashtra, India, India

Abstract

At present, COVOID-19 has created such a worse pandemic situation worldwide. The virus is responsible for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). During quarantine, outside, there is the danger of getting physically sick due to infection (spreads with social contact) and inside due to mental and psychological stiffness. Once found proof of a range of psychological conditions during previous epidemics such as SARS, from post-traumatic stress symptoms to confusion, anger, depression, stress, insomnia, and emotional exhaustion. It is essential to look over schedule during this lockdown. From the sleeping time, exercise, diet, remain physically and mentally calm and relaxed. An estimated 2.6 billion people – one-third of the world's population – are living under some lockdown or quarantine. This is arguably the most massive psychological experiment ever conducted. There was no option to combat the COVID-19 crisis. Lockdown helps to break the chain of virus scattering in society and to minimize the disease rate as well as control the mortality rate. People didn’t seem aware of how to face or schedule the lockdown period, and that creates a panic situation in the society. Thus, it is necessary to plan out the lockdown schedule to overcome physical as well as mental illness. 

Full text article

Generated from XML file

Authors

Tejas N. Wanjari
Gaurav Sawarkar
drsawarkar.gaurav@gmail.com (Primary Contact)
Tejas N. Wanjari, & Gaurav Sawarkar. (2020). Lockdown Lifestyle: Engaging the invisible Enemy. International Journal of Research in Pharmaceutical Sciences, 11((SPL 1), 491–495. Retrieved from https://ijrps.com/home/article/view/1548

Article Details

No Related Submission Found